Nucleotide based covalent inhibitors of KRas can only be efficient in vivo if they bind reversibly with GTP-like affinity
Abstract Simple reversible competitive inhibition of nucleotide binding of GTP to Ras family GTPases has long been recognized as an unlikely approach to manipulating the activity of such proteins for experimental or therapeutic purposes. This is due to the high affinity of GTP to GTPases coupled wit...
Guardado en:
Autores principales: | Matthias P. Müller, Sadasivam Jeganathan, Angelika Heidrich, Jeremy Campos, Roger S. Goody |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2905962a45d8475ebe1fcab659106648 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
GTP binding to translation factor eIF2B stimulates its guanine nucleotide exchange activity
por: Christopher J. Kershaw, et al.
Publicado: (2021) -
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
por: Naiara Santana-Codina, et al.
Publicado: (2018) -
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
por: Jean-Marc Taymans, et al.
Publicado: (2011) -
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
por: Wen-Hao Guo, et al.
Publicado: (2020) -
Nucleotide binding by the widespread high-affinity cyclic di-GMP receptor MshEN domain
por: Yu-Chuan Wang, et al.
Publicado: (2016)